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DIAGNOSIS PLEASE

Case 213: Primary Splenic
Angiosarcoma1

John J. Krol, MD
Vera V. Krol, MD
Adrian Dawkins, MD
Halemane S. Ganesh, MD

History

Part one of this case appeared 4 months previously
and may contain larger images.
Published online
10.1148/radiol.14110919

Content code:

Radiology 2015; 274:298–303

A 75-year-old woman with a medical history of gastroesophageal reflux disease and type II diabetes presented
to the hospital with a 3-month history of gradually worsening headaches, vague upper abdominal pain, and lower
back pain. The patient denied fevers, night sweats, contact with sick individuals, occupational exposure to infection, bleeding, immunodeficiency, intravenous drug use,
alcohol or tobacco abuse, history of malignancy, family
history of genetic disorders, and international travel.
Physical examination revealed a skin-colored mass protruding from the right side of her forehead, but there
were no other notable abnormalities. Her diabetes was
managed with diet, and the only prescription medication
she was taking was esomeprazole. She was not taking anticoagulants. Initial laboratory work-up revealed anemia and
profound thrombocytopenia (hemoglobin level, 9.4 g/dL;
platelet count, 16 3 109/L); these were refractory to aggressive treatment, including plasmapheresis, immunosuppression with prednisolone, and numerous transfusions.
Contrast material–enhanced magnetic resonance (MR)
imaging of the head was performed at admission to further evaluate the patient’s headache and the mass on the
patient’s forehead. Ultrasonography (US) of the abdomen
was performed to evaluate the cause of abdominal pain.
The discovery of liver lesions at US led us to perform
contrast-enhanced computed tomography (CT) of the
chest, abdomen, and pelvis. Contrast-enhanced MR imaging of the abdomen was performed to narrow the diagnostic considerations for the lesions identified at CT. Bone
marrow biopsy revealed no evidence of infectious or neoplastic processes. Endoscopy and colonoscopy were performed; however, they revealed no abnormalities. Further
laboratory work-up included extensive testing for parasites, fungi, bacteria, and viruses, including the human
immunodeficiency virus (HIV). All of the results were negative. On the 17th day of admission, the patient became
acutely unresponsive, her condition deteriorated rapidly,
and she died. Unenhanced head CT was performed at the
time of the patient’s acute decompensation.
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Imaging Findings
Figure 1 is an axial contrast-enhanced
T1-weighted MR image of the head
that was obtained to assess the patient’s initial report of headache and
the lesion on the patient’s forehead.

There is an extra-axial peripherally enhancing soft-tissue lesion extending
through the diploic space and showing
mass effect in the right frontal lobe.
Figure 2 is a transverse gray-scale US
image of the upper abdomen obtained
to evaluate the patient’s vague upper
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Figure 2

Figure 4

Figure 2: Transverse gray-scale US image of the
upper abdomen shows ill-defined heterogeneous
hypoechoic lesions. Some of the lesions contain
internal echoes, and some have relatively hyperechoic rims. The visualized hepatic parenchyma
demonstrates diffuse heterogeneity.

Figure 1: Axial T1-weighted (repetition time
msec/echo time msec, 400/17; 5-mm section
thickness) contrast-enhanced MR image of the brain
(10 mL of gadopentetate dimeglumine administered
intravenously over 15 seconds, Magnevist; Bayer
Healthcare Pharmaceuticals, Leverkusen, Germany)
shows a peripherally enhancing soft-tissue lesion
extending through the diploic space into the parenchyma of the right frontal lobe.

abdominal pain. This image shows illdefined heterogeneous hypoechoic lesions, some of which contain internal
echoes. There is a heterogeneous rim
surrounding some of the lesions. The
visualized hepatic parenchyma demonstrates diffuse heterogeneity. These
lesions were not suspected clinically
and shifted the focus to differential diagnostic considerations of infectious
and neoplastic processes; however,
laboratory tests did not enable us to
confirm a specific diagnosis. Torso CT
was performed with intravenous administration of contrast material to establish the distribution of lesions and
to identify the source. Figure 3 is a
representative image of the chest obtained through the breasts that shows
no breast or lung mass. Figure 4a is an
axial dynamic contrast-enhanced CT
image obtained in the arterial phase
that depicts multiple complex low-attenuation lesions throughout the liver.
A similar large complex low-attenuation lesion is seen in the spleen. There
Radiology: Volume 274: Number 1—January 2015
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Figure 3

Figure 3: Axial contrast-enhanced CT image of
the chest acquired during the arterial phase (80 mL
of iohexol 300 administered at a rate of 4 mL/sec,
Omnipaque 300; GE Healthcare, Milwaukee, Wis).
There is no lung or breast mass.

is slight heterogeneous enhancement
of the splenic lesion but no enhancement of the liver lesions. Figure 4b
shows the pancreas is fatty and atrophied, without focal mass. There is no
renal mass. We identified soft-tissue
masses in the L1 and L2 vertebral
bodies on this image. In combination
with chest CT images, the dynamic
contrast-enhanced CT images helped
us exclude the most common malignancies, including those in the breast,
lung, pancreas, uterus, cervix, ovary,
and kidney. Endoscopy and colonoscopy were also performed and revealed
no mass, which enabled us to virtually
exclude gastric and colon primary malignancies. Infectious and neoplastic
processes were still the major differen-

radiology.rsna.org

Figure 4: Axial contrast-enhanced CT images of
the liver during the arterial phase (80 mL of iohexol
300 administered at a rate of 4 mL/sec) show (a) a
large complex low-attenuation lesion in the spleen
and multiple complex low-attenuation lesions
throughout the liver and (b) fatty atrophy of the
pancreas, without focal mass, and no renal mass.

tial considerations; thus, fluorodeoxyglucose (FDG) combined positron
emission tomography (PET) and CT
were ordered in an to attempt to distinguish between the two major differential diagnoses. Figure 5 is the FDG
PET/CT image, which did not show
abnormal FDG uptake in the lesions
and added little information to the
clinical picture. MR images of the abdomen were then obtained to better
characterize the hepatic and splenic
lesions. Figure 6 is an ultrafast spinecho sequence that reveals a large heterogeneous T2 hyperintense lesion in
the spleen and multiple heterogeneous
T2 hyperintense lesions throughout
the liver. Figure 7 was obtained with a
dynamic postcontrast axial T1-weighted
299
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Figure 8

Figure 5: Representative axial FDG (13.9 mCi,
infused at a blood glucose level of 113 mg/dL and
incubated for 62 minutes) PET/CT image through
the upper abdomen shows low-grade uptake of the
radiotracer in the periphery of the cystic necrotic
lesions within the spleen and liver.
Figure 8: Unenhanced axial CT image of the head
at the time of acute mental status changes and
clinical deterioiration shows acute subdural and
epidural hemorrhage causing mass effect in the
brain and subfalcine herniation.

Figure 6

Figure 7: Axial T1-weighted (4.3/2, 2-mm section
thickness) dynamic contrast-enhanced ultrafast
gradient-echo MR images of the abdomen (10 mL
of gadopentetate dimeglumine) obtained during the
(a) early and (b) late arterial phases. Images show
areas of heterogeneous enhancement of the large
splenic lesion and several of the hepatic lesions (a)
and an additional peripherally enhancing mass in
the L1 vertebral body (b).

Figure 6: Coronal T2-weighted (900/78, 6-mm
section thickness) ultrafast spin-echo MR image of
the abdomen (Symphony; Siemens Medical
Systems, Erlangen, Germany) shows a large
complex T2 heterogeneous hyperintense lesion in
the spleen and multiple heterogeneous T2 hyperintense lesions throughout the liver.

fat-suppressed gradient-echo sequence,
and it depicts areas of heterogeneous
enhancement of the large splenic lesion and peripheral enhancement of
several of the hepatic lesions on the
early arterial phase image (Fig 7a).
Figure 7b was obtained in the late arterial phase and shows an additional
peripherally enhancing lesion in the L1
vertebral body. The imaging and laboratory results failed to yield a specific
300

diagnosis, so biopsy was requested.
Angiosarcoma was not suspected by
those who performed the procedure.
Routine CT-guided biopsy of one of the
liver lesions was attempted, but the results were nondiagnostic, as the lesions yielded only inflammatory cells
and necrotic tissue. Substantial intraperitoneal bleeding was recognized
several hours after biopsy and required
multiple transfusions. The patient remained hemodynamically stable; however, at autopsy several days later,
there was an estimated 3–4 L of blood
in the abdomen. Figure 8 is an axial
CT image of the head without intravenous contrast material obtained at the
time of the patient’s spontaneous acute
clinical decompensation several days
after biopsy. It shows the extra-axial
mass associated with acute extra-axial

Figure 9

Figure 9: Gross pathologic image of the liver
shows parenchymal involvement by ill-defined hemorrhagic and necrotic foci of angiosarcoma.

hemorrhage and associated mass effect, including subfalcine herniation.
Figure 9 is the liver specimen at autopsy. It shows parenchymal involvement by ill-defined, hemorrhagic, and
necrotic foci of angiosarcoma. Figure 10
is the spleen specimen at autopsy. It
shows gross organ distortion and involvement by one dominant lesion and
numerous cystic, necrotic, and hemorrhagic lesions that surround the larger
lesion. Figure 11 is the histologic slice
of the spleen. It shows an area of haphazard anastomosis of poorly formed
vascular channels adjacent to an area
of hemorrhage and necrosis. The vas-
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Figure 10

Figure 11

Figure 10: Gross pathologic image of the spleen
shows a markedly distorted organ with one dominant lesion and numerous surrounding cystic, necrotic, and hemorrhagic lesions.

cular channels are lined by highly pleomorphic epithelioid cells of high nuclear grade. The autopsy findings of a
large dominant splenic angiosarcoma
and multiple smaller foci of angiosarcoma involving the liver and bones enabled us to confirm the diagnosis of
splenic angiosarcoma.

Discussion
The distribution, behavior, and imaging
characteristics of the lesions suggest a
neoplastic or infectious origin. There is
easily identifiable multifocal disease,
with one of the lesions extending
through the skull and compressing the
right frontal lobe parenchyma. Thus,
the most likely categories of disease
processes that would explain these findings are infection and neoplasm.
The major infectious differential considerations for this patient would be ecchinococcal infection, bacillary angiomatosis, schistosomiasis, and multiple
abscesses, including those caused by
amoebic species. Abscesses and bacillary angiomatosis virtually always cause
high fevers and leukocytosis and are
therefore unlikely, given this patient’s
history and laboratory results. Ecchinococcal infection was excluded clinically
with ecchinococcal antigen testing.
Schistosomiasis represents a reasonable
differential diagnosis for the liver lesions, but it would not explain the softtissue mass in the skull. Other overwhelmingly rare or atypical infections
Radiology: Volume 274: Number 1—January 2015
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Figure 11: Hematoxylin-eosin stained slice of the
spleen (original magnification, 320) shows an area
of haphazard anastomosis of poorly formed vascular
channels adjacent to an area of hemorrhage and
necrosis. The vascular channels are lined by highly
pleomorphic epithelioid cells of high nuclear grade.

were excluded because of the negative
HIV test results, a lack of immunodeficiency, and a negative history of travel.
In summary, the lack of signs and symptoms of infection and the negative results of extensive infectious disease testing make an infectious origin unlikely.
An extensive neoplastic process
would better explain the behavior and
distribution of the lesions in this patient.
The most likely cause of multiple hepatic, splenic, and bone lesions would be
metastatic disease from a common primary malignancy, such as the lung,
breast, pancreas, kidney, or colon. Additionally, diffuse malignant processes,
such as lymphoma, leukemia, or melanoma, would be a reasonable consideration. Primary breast, renal, lung, pancreatic, and gastrointestinal malignancies
were excluded on the basis of the normal appearance of these organs at CT,
other imaging studies, and endoscopy.
Melanoma is less likely, as it tends to
appear as T1 shortening on MR images
from the cellular melanin content and as
arterial phase enhancement on dynamic
images (1). The centrally necrotic lesions could reasonably represent a common appearance of melanoma in a patient
undergoing
chemotherapy;
however, this patient never underwent
treatment for malignancy (2). Leukemia
and lymphoma will be discussed later in
this report.
Since metastases from the most
common malignancies in this case are

radiology.rsna.org

considered unlikely, the differential diagnosis for multiple hepatic lesions
should be expanded to include other,
more rare processes. Lymphatic malformations and multiple hemangiomas
could have an appearance similar to
that of the hepatic and splenic lesions
seen in this patient, but this would not
explain the spontaneously hemorrhaging lesion in the skull. Kaposi sarcoma
is known to involve the liver in patients
with HIV; however, this patient did not
have HIV, and primary hepatic or
splenic Kaposi sarcomas are very rare.
Epithelioid hemangioendothelioma is
an important differential diagnosis in
this case. Epithelioid hemangioendothelioma is often multifocal within the
liver and can produce similar-appearing lesions at imaging; however, splenic
and bone metastases are extremely
rare (3). Primary liver hemangiopericytoma is very rare and may mimic angiosarcoma (4). However, it is less
common than angiosarcoma and preferentially metastasizes to lung and
bone (5).
There are several primary splenic
neoplasms that could have imaging
characteristics similar to those in this
case. Lymphoma and leukemia could
explain the distribution of the lesions,
as well as the anemia and thrombocytopenia in this patient. However, these
are virtually excluded in the setting of
a negative bone marrow biopsy. Littoral cell angioma produces hypoattenuating splenic lesions and can have malignant characteristics; however, bone
metastases are rare in this diagnosis
(6). Primary splenic hemangiopericytoma is a very rare neoplasm that
mimics splenic angiosarcoma in many
ways, but it is less common than angiosarcoma and tends to metastasize to
lung and bone (5).
Metastatic splenic angiosarcoma is
the best diagnosis in this case. The
spleen is the most likely primary organ
in this patient for two reasons: First, the
dominant lesion in the spleen is much
larger than the metastases elsewhere in
the body. Second, the pattern of metastasis demonstrated by imaging is most
consistent with the pattern observed in
patients with splenic angiosarcoma (7).
301
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Primary splenic angiosarcoma is a rare
aggressive neoplasm with the propensity
to spontaneously hemorrhage, as demonstrated by this patient’s skull metastasis. These lesions are known to hemorrhage significantly after biopsy, which
was also seen in this patient, who had an
estimated 3–4 L of blood in her abdomen at autopsy. Radiologists should be
familiar with the appearance of angiosarcoma, as well as the potential for abnormal platelets with this diagnosis, so
that they can make informed decisions
regarding potential biopsy of similar-appearing lesions. The mean age for
women to develop splenic angiosarcoma
is 68 years (8). The most common presenting symptom is vague abdominal
pain, as in this patient. This pain can be
acute if there is spontaneous splenic
rupture. Chest pain, weight loss, and fatigue are other signs and symptoms at
presentation in a minority of patients.
The most common laboratory abnormality is cytopenia, which was seen in up to
91% of patients in one large study (9). In
that study, anemia was found in 62% of
patients, and thrombocytopenia was
found in up to 33% of patients with a
diagnosis of angiosarcoma. This patient
had both of these laboratory abnormalities. In spite of hepatic metastases being common in the setting of primary
splenic angiosarcoma, hepatic enzyme
test results are typically within normal
limits (8). The most common sites of
metastases for splenic angiosarcoma are
liver and bone, specifically the vertebrae, as in this patient; however, lung
metastases are not uncommon. Abdominal and mesenteric lymphadenopathy is
reported less frequently (7). Treatment
often includes splenectomy and chemotherapy, but prognosis is poor and most
patients die within 1 year of initial diagnosis despite treatment (9).
The imaging findings of primary
splenic angiosarcoma are somewhat
variable, but certain trends appear to
exist. The spleen is commonly enlarged,
measuring more than 12 cm in maximum dimension. This patient’s spleen
measured 15.7 cm in maximum dimension. The majority of patients have diffuse involvement of the spleen either as
a single large lesion or as a large mass
302
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with multiple smaller nodules. The lesions frequently show central necrosis
with a rim of soft tissue. At Doppler
US, the necrotic centers of the lesions
tend to appear cystic, with internal echoes secondary to debris or hemorrhage,
while the soft-tissue rim generally appears heterogeneous in echo texture.
Typically, on both CT and MR images,
the primary splenic lesion is poorly defined (60% of cases) and irregularly
shaped, and it shows irregular heterogeneous enhancement on postcontrast
images (7). On T1-weighted MR images, the splenic and hepatic lesions
tend to appear hypointense in the center and periphery, with focal areas of
high signal intensity in the necrotic center in some of the lesions. On T2weighted MR images, the splenic and
hepatic lesions appear as ill-defined
heterogeneously hyperintense lesions
(7). There has been only one published
case report in the English literature to
date of splenic primary angiosarcoma
imaged with FDG PET/CT, and that
case showed avid uptake of FDG in the
neoplasm (10). In the current case,
FDG PET/CT showed no significant
avidity for FDG, which is best explained
by the cystic and necrotic qualities of
the lesions in this patient (11). This
case demonstrates the most common
imaging findings of splenic angiosarcoma for US, CT, and MR imaging.
Splenic angiosarcoma is a rare aggressive neoplasm that presents many
challenges to the clinician and radiologist. The clinical presentation is often
nonspecific, and the imaging characteristics that differentiate angiosarcoma
from more common diagnoses can be
subtle. The importance of knowing the
imaging and clinical features of splenic
angiosarcoma is most crucial when one
is considering lesion biopsy. As was
seen in this patient, this neoplasm is
known to spontaneously hemorrhage.
Biopsy will produce hemorrhage, as
was also seen in this patient, and most
importantly, there is potential to produce hemorrhage that is difficult to
control. Additionally, patients may have
thrombocytopenia, which can further
alter the ability to achieve hemostasis
after the procedure. This knowledge

will help the physician to choose the
best technique and location for biopsy
and to manage potentially catastrophic
complications.
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Congratulations to the 63 individuals
and four resident groups that submitted the most likely diagnosis (metastatic angiosarcoma) for Diagnosis
Please, Case 213. The names and locations of the individuals and resident
groups, as submitted, are as follows:

Individual responses
Sasha Bhan, Hamilton, Ontario, Canada
Manon N. Braat, MD, Utrecht, the Netherlands
Douglas C. Brown, MD, Virginia Beach, Va
Ian A. Burgess, MD, Manly, New South Wales,
Australia
Michael H. Childress, MD, Washington, DC
Haris Chrysikopoulos, Corfu, Greece, Greece
Marc G. De Baets, MD, Collina d'Oro, Ticino,
Switzerland
Peter de Baets, MD, Damme, Belgium
Thaworn Dendumrongsup, MD, Songkhla,
Thailand
Seyed A. Emamian, MD, PhD, Rockville, Md
Akira Fujikawa, MD, Tokyo, Japan
Toshihiro Furuta, MD, PhD, Bunkyo-ku, Tokyo,
Japan
Gilles Genin, Annecy, France
Mark G. Goldshein, MD, Andover, Mass
Alvaro Gomez Naar, MD, Salta Capital, Salta,
Argentina
Wataru Gonoi, MD, PhD, Bunkyo-ku, Tokyo,
Japan
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Akifumi Hagiwara, MD, Tokyo, Japan
Stefan Hamelin, MD, Saint Charles, Mo
Osamu Hasegawa, MD, Koriyama, Fukushima,
Japan
D. C. Heasley, Jr, MD, Dallas, Tex
Noriatsu Ichiba, MD, Otsu, Shiga, Japan
Takashi Ikeuchi, Moriyama, Shiga, Japan
Akitoshi Inoue, MD, Otsu, Shiga, Japan
Shanigarn Keoplung, MD, Muang Nonthaburi,
Nonthaburi, Thailand
Patrick Kiely, MBBCh, Limerick, Ireland
Takao Kiguchi, MD, Niigata, Japan
Osamu Kizu, MD, Ohtsu, Japan
Mario A. Laguna, MD, Franklin, Wis
Matthew L. Levine, MD, Nashua, NH
Satoshi Matsushima, MD, Tokyo, Japan
Manabu Minami, MD, PhD, Yokohama, Japan
Kenichi Mizuki, MD, Hamamatsu-shi, Shizuokaken, Japan
Toshio Moritani, MD, PhD, Iowa City, Iowa
Kyoko Nagai, MD, Yokohama, Japan
Hirotsugu Nakai, MD, Otsu, Shiga, Japan
Tomokazu Nishiguchi, MD, PhD, Osaka, Japan
Mizuki Nishino, MD, Boston, Mass
Hiroshi Nobusawa, MD, PhD, Ota, Tokyo,
Japan
Ioannis E. Papachristos, MD, Agrinio, Greece
Daniel C. Rappaport, MD, Toronto, Ontario,
Canada
Mathieu H. Rodallec, MD, Paris, France
Akihiko Sakata, MD, Kyoto, Japan
Shuichi Satoh, MD, Oota-ku, Tokyo, Japan
Pierre Schnyder, MD, La Conversion,
Switzerland
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Matthew P. Shapiro, MD, Charlottesville, Va
Hideki Shima, MD, Narita, Chiba, Japan
Taro Shimono, MD, Osaka, Japan
Gayathri Sreedher, MBBS, MD, Pittsburgh, Pa
Hongliang Sun, MD, Beijing, China
Eliko Tanaka, MD, Yokohama, Japan
Satoshi Tatsuno, MD, Ichikawa, Chiba, Japan
Yasuyo Teramura, MD, Tokorozawa, Saitama,
Japan
Eugene Tong, MD, Austin, Tex
Ulysses S. Torres, MD, Sao Paulo, Brazil
Meric Tuzun, MD, Ankara, Turkey
Haruo Watanabe, MD, Gifu, Japan
Tatsuya Yamamoto, MD, Yoshida-gun, Fukui,
Japan
Koichiro Yasaka, MD, Tokyo, Japan
Kurata Yasuhisa, MD, Kobe, Hyogo, Japan
Hajime Yokota, MD, Kyoto, Japan
Rika Yoshida, MD, Utsunomiya, Tochigi, Japan
Kaneko You, Gifu, Japan
Ahmed Zidan, MD, Barcelona, Spain

Resident group responses
ICESP Residents, Sao Paulo, Brazil
Mater Dei Hospital Radiology Residents, Malta
Mie University Hospital Radiology Residents,
Tsu, Mie, Japan
Prince of Songkla University Radiology
Residents, Songkla, Thailand
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